Literature DB >> 18542991

Luminal ATP-induced contraction of rabbit pulmonary arteries and role of purinoceptors in the regulation of pulmonary arterial pressure.

Eun Bok Baek1, Hae Young Yoo, Su Jung Park, Hyang Sun Kim, Seong Deok Kim, Yung E Earm, Sung Joan Kim.   

Abstract

The effects of luminal ATP between rabbit pulmonary (PAs) and coronary arteries (CAs) were compared to understand the role of purinoceptors in the regulation of pulmonary arterial pressure (PAP) under hypoxia. Diameters of vessels were video analyzed under luminal perfusion. ATP-induced membrane currents and intracellular Ca(2+) signals ([Ca(2+)](i)) were compared in pulmonary (PASMCs) and coronary myocytes (CASMCs) using patch clamp and spectrofluorimetry. PAP was measured in perfused lungs under ventilation. Luminal ATP induced constriction of rabbit PAs in the presence of endothelium. In contrast, CAs showed dilating responses to luminal ATP even in the absence of endothelium. In PASMCs, both P2X-mediated inward current and P2Y-mediated store Ca(2+) release were consistently observed. In contrast, CASMCs showed neither P2X nor P2Y responses. In the perfused lungs, hypoxia-induced PAP increase was decreased by suramin, a purinergic antagonist. A luminal application of alpha,beta-meATP largely increased PAP, whereas UTP decreased PAP. The combined application of P2X- and P2Y-selective agonists (alpha,beta-meATP and UTP) increased PAP. However, the perfusion of ATP alone decreased PAP, and the ATP-induced PAP decrease was affected neither by adenosine receptor antagonist nor by nitric oxide synthase inhibitor. In summary, although the luminal ATP constricts isolated PAs and suramin attenuated the HPV of perfused lungs, the bimodal responses of PAP to purinergic agonists indicate that the luminal ATP regulates pulmonary circulation via complex signaling interactions in situ.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18542991     DOI: 10.1007/s00424-008-0536-z

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  27 in total

1.  Coronary vasodilator properties of purine and pyrimidine derivatives.

Authors:  M M WOLF; R M BERNE
Journal:  Circ Res       Date:  1956-05       Impact factor: 17.367

2.  Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase.

Authors:  D Communi; C Govaerts; M Parmentier; J M Boeynaems
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

3.  Red-blood-cell augmentation of hypoxic pulmonary vasoconstriction: hematocrit dependence and the importance of nitric oxide.

Authors:  S Deem; E R Swenson; M K Alberts; R G Hedges; M J Bishop
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

4.  Segmental pulmonary vascular responses to ATP in rat lungs: role of nitric oxide.

Authors:  T S Hakim; L Ferrario; J C Freedman; R E Carlin; E M Camporesi
Journal:  J Appl Physiol (1985)       Date:  1997-03

5.  Extracellular ATP signaling in the rabbit lung: erythrocytes as determinants of vascular resistance.

Authors:  Randy S Sprague; Jeffrey J Olearczyk; Dana M Spence; Alan H Stephenson; Robert W Sprung; Andrew J Lonigro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-04-10       Impact factor: 4.733

6.  The inhibitory effect of various phenols upon ATP-induced vasoconstriction in isolated perfused rabbit lungs.

Authors:  P K Lunde; B A Waaler; L Walloe
Journal:  Acta Physiol Scand       Date:  1968-03

7.  Mechanisms of hypoxic pulmonary vasoconstriction: can anyone be right?

Authors:  J P Ward; P I Aaronson
Journal:  Respir Physiol       Date:  1999-05-03

8.  Potassium channels modulate hypoxic pulmonary vasoconstriction.

Authors:  S A Barman
Journal:  Am J Physiol       Date:  1998-07

9.  Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia.

Authors:  G R Bergfeld; T Forrester
Journal:  Cardiovasc Res       Date:  1992-01       Impact factor: 10.787

10.  Nucleotide coronary vasodilation in guinea pig hearts.

Authors:  Mark W Gorman; Kayoko Ogimoto; Margaret V Savage; Kenneth A Jacobson; Eric O Feigl
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-05-22       Impact factor: 4.733

View more
  6 in total

1.  Purinergic receptor stimulation induces calcium oscillations and smooth muscle contraction in small pulmonary veins.

Authors:  Mauricio Henriquez; Marcelo Fonseca; Jose F Perez-Zoghbi
Journal:  J Physiol       Date:  2018-05-23       Impact factor: 5.182

2.  A Ca²⁺-dependent chloride current and Ca²⁺ influx via Ca(v)1.2 ion channels play major roles in P2Y receptor-mediated pulmonary vasoconstriction.

Authors:  Callum Mitchell; Nawazish-i-Husain Syed; Alison M Gurney; Charles Kennedy
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

3.  Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists.

Authors:  Markie O Dales; Callum Mitchell; Alison M Gurney; Robert M Drummond; Charles Kennedy
Journal:  Purinergic Signal       Date:  2022-08-26       Impact factor: 3.950

4.  Optimization of isolated perfused/ventilated mouse lung to study hypoxic pulmonary vasoconstriction.

Authors:  Hae Young Yoo; Amy Zeifman; Eun A Ko; Kimberly A Smith; Jiwang Chen; Roberto F Machado; You-Yang Zhao; Richard D Minshall; Jason X-J Yuan
Journal:  Pulm Circ       Date:  2013-04       Impact factor: 3.017

5.  Inhibition of hypoxic pulmonary vasoconstriction of rats by carbon monoxide.

Authors:  Hae Young Yoo; Su Jung Park; Jae Hyon Bahk; Sung Joon Kim
Journal:  J Korean Med Sci       Date:  2010-09-17       Impact factor: 2.153

Review 6.  Integrative understanding of hypoxic pulmonary vasoconstriction using in vitro models: from ventilated/perfused lung to single arterial myocyte.

Authors:  Hae Young Yoo; Su Jung Park; Hae Jin Kim; Woo Kyung Kim; Sung Joon Kim
Journal:  Integr Med Res       Date:  2014-09-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.